Stockscreener 앱 받기
13.94
2.88%
0.39
시간 외 거래:
13.96
0.02
+0.14%
전일 마감가:
$13.55
열려 있는:
$13.52
하루 거래량:
732.00K
Relative Volume:
0.71
시가총액:
$613.70M
수익:
$78.02M
순이익/손실:
$-73.37M
주가수익비율:
-10.56
EPS:
-1.32
순현금흐름:
$-62.06M
1주 성능:
+6.57%
1개월 성능:
-19.28%
6개월 성능:
-7.68%
1년 성능:
-35.91%
1일 변동 폭
$13.25
$14.40
1주일 범위
$12.71
$15.53
52주 변동 폭
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
명칭
Beta Bionics Inc
전화
949-427-7785
주소
11 HUGHES, IRVINE
Compare BBNX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
13.94 | 596.53M | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-09 | 개시 | UBS | Buy |
| 2026-01-27 | 개시 | TD Cowen | Hold |
| 2026-01-09 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-10-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-06-12 | 개시 | Lake Street | Buy |
| 2025-05-30 | 개시 | Goldman | Neutral |
| 2025-05-30 | 개시 | Wolfe Research | Outperform |
| 2025-02-24 | 개시 | BofA Securities | Buy |
| 2025-02-24 | 개시 | Lake Street | Buy |
| 2025-02-24 | 개시 | Leerink Partners | Outperform |
| 2025-02-24 | 개시 | Piper Sandler | Overweight |
| 2025-02-24 | 개시 | Stifel | Buy |
| 2025-02-20 | 개시 | Ladenburg Thalmann | Neutral |
| 2025-02-20 | 개시 | Robert W. Baird | Neutral |
모두보기
Beta Bionics Inc 주식(BBNX)의 최신 뉴스
Why Beta Bionics Inc. stock appeals to dividend seekersJuly 2025 Analyst Calls & Stock Portfolio Risk Management - mfd.ru
Will Beta Bionics Inc. stock remain a Wall Street favoriteNew Guidance & Risk Controlled Swing Alerts - mfd.ru
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Financial Times
Why is Beta Bionics Inc. stock going downWeekly Gains Report & Safe Entry Zone Identification - mfd.ru
Does Beta Bionics Inc. have consistent dividend growthPortfolio Update Report & Weekly Breakout Watchlists - mfd.ru
UBS Group Upgrades Beta Bionics (NASDAQ:BBNX) to "Strong-Buy" - MarketBeat
Beta Bionics (NASDAQ:BBNX) Trading Up 7.9%Here's What Happened - MarketBeat
Will Beta Bionics, Inc. (BBNX) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Essex Investment Management Co. LLC Takes Position in Beta Bionics, Inc. $BBNX - MarketBeat
Beta Bionics (NASDAQ:BBNX) Shares Gap UpTime to Buy? - MarketBeat
Resistance Check: How liquid is Beta Bionics Inc stockSwing Trade & Real-Time Chart Pattern Alerts - baoquankhu1.vn
UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target - marketscreener.com
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
UBS initiates coverage on Beta Bionics stock with Buy rating By Investing.com - Investing.com Nigeria
UBS initiates coverage on Beta Bionics stock with Buy rating - Investing.com
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Beh - GuruFocus
Faruqi & Faruqi Investigates Aquestive Therapeutics for Investor Losses - intellectia.ai
Beta Bionics, Inc.'s (NASDAQ:BBNX) Popularity With Investors Under Threat As Stock Sinks 58% - simplywall.st
Artificial Pancreas System Market is expected to reach US$ - openPR.com
Stifel Nicolaus Lowers Beta Bionics (NASDAQ:BBNX) Price Target to $25.00 - MarketBeat
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc.BBNX - Chartmill
Beta Bionics receives FDA warning letter - MedTech Dive
TD Cowen reiterates Hold rating on Beta Bionics stock amid FDA warning letter - Investing.com Australia
TD Cowen reiterates Hold rating on Beta Bionics stock amid FDA warning letter By Investing.com - Investing.com South Africa
Beta Bionics stock holds steady as TD Cowen reiterates $17 price target By Investing.com - Investing.com South Africa
Beta Bionics stock holds steady as TD Cowen reiterates $17 price target - Investing.com Canada
Truist Financial Has Lowered Expectations for Beta Bionics (NASDAQ:BBNX) Stock Price - MarketBeat
BBNX: Truist Securities Lowers Price Target While Maintaining 'B - GuruFocus
Balanced Risk-Reward Amid FDA Warning Letter Keeps Beta Bionics at Hold - TipRanks
Truist Securities lowers Beta Bionics stock price target to $25 from $37 By Investing.com - Investing.com South Africa
Truist Securities lowers Beta Bionics stock price target to $25 from $37 - Investing.com Nigeria
Truist Trims Price Target on Beta Bionics to $25 From $37, Keeps Buy Rating - marketscreener.com
Beta Bionics, Inc. (NASDAQ:BBNX) Short Interest Down 24.0% in January - MarketBeat
Beta Bionics Receives FDA Warning Letter, Begins Remediation - TipRanks
Beta Bionics Receives FDA Warning Letter - TradingView
FDA warning letter hits Beta Bionics (NASDAQ: BBNX) but Mint plan stands - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc.AQST - PR Newswire
Aug Volume: Will Beta Bionics Inc stock benefit from M AEarnings Overview Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall ... - Caledonian Record
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Beta Bionics, Inc. (BBNX) And Encourages Shareholders to Connect - accessnewswire.com
Beta Bionics stock initiated with Hold rating at TD Cowen By Investing.com - Investing.com Nigeria
TD Cowen Initiates Coverage of Beta Bionics (BBNX) with Hold Recommendation - Nasdaq
Today's Analyst Rating: BBNX Receives 'Hold' Rating from TD Cowe - GuruFocus
Beyond The Numbers: 4 Analysts Discuss Beta Bionics Stock - Benzinga
Beta Bionics posts strong results in inaugural public company year - BioWorld MedTech
Beta Bionics Inc (BBNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):